Evidence map›Paper›PMID 32225104›Full record

ReviewInternational journal of molecular sciences2020

The Emerging Role of Curcumin in the Modulation of TLR-4 Signaling Pathway: Focus on Neuroprotective and Anti-Rheumatic Properties.

Maria Antonietta Panaro, Addolorata Corrado, Tarek Benameur, Cantatore Francesco Paolo, Daniela Cici, Chiara Porro

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Toll like receptor 4 (TLR4) in neuroinflammation: From acute hemorrhagic stroke to chronic neurodegeneration.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Novel Insights into the Therapeutic Potential of Curcumin and Derivatives.International journal of molecular sciences · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Maria Antonietta PanaroDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, 70125 Bari, Italy.
Addolorata CorradoRheumatology Clinic, Department of Medical and Surgical Sciences, University of Foggia, 71121 Foggia, Italy.
Tarek BenameurCollege of Medicine, Department of Biomedical Sciences, King Faisal University, 31982, Al-Ahsa, Saudi Arabia.
Cantatore Francesco PaoloRheumatology Clinic, Department of Medical and Surgical Sciences, University of Foggia, 71121 Foggia, Italy.
Daniela CiciRheumatology Clinic, Department of Medical and Surgical Sciences, University of Foggia, 71121 Foggia, Italy.
Chiara PorroDepartment of Clinical and Experimental Medicine, University of Foggia, 71121 Foggia, Italy.
University of Foggia · ITKing Faisal University · SAUniversity of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products have been used in medicine for thousands of years. Given their potential health benefits, they have gained significant popularity in recent times. The administration of phytochemicals existed shown to regulate differential gene expression and modulate various cellular pathways implicated in cell protection. Curcumin is a natural dietary polyphenol extracted from

Indexed as

AnimalsAntirheumatic AgentsCurcuminHumansNervous System DiseasesNeuroprotective AgentsRheumatic DiseasesSignal TransductionToll-Like Receptor 4Antirheumatic AgentsCurcuminNeuroprotective AgentsToll-Like Receptor 4CurcuminexosomesmiRNANeuroinflammatory diseasesRheumatic DiseasesTLR-4

Identifiers

PMID32225104
PMCPMC7177421
OpenAlexW3013063515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.